The solution of isopropyl tobly bromide for healthy meta-inhalation was approved for listing.

Introduction: Inhalation of ammonium isopropyl bromide solution is one of the main drugs for the treatment of COPD.
4, Health Meta-Pharmaceuticals announced that it had received the Drug Registration Certificate for Inhalation of Isopropyl Tobhamide Solution approved by the State Drug Administration.
isopropyl tobly bromide solution can be combined with inhaled beta-subjector agitants to treat reversible gas vessel obstruction caused by acute or chronic asthma.
products for the company's independent research and development products.
Isopropropyl bromide is an anticholinelic energy drug with strong bronchial smooth muscle relaxation, which can significantly improve lung function and exercise tolerance in patients with chronic obstructive pulmonary disease (COPD), relieve the symptoms of breathing difficulties, improve sleep and quality of life, and is one of the main drugs for COPD treatment.
isopropanium bromide with inhaled beta-subjector agitants and is widely used to treat acute asthma attacks.
isopropyl tobominate solution was first developed by Boehringer-Ingelheim, which was approved for listing in the UK in August 1986 and entered the Chinese market in 2004.
According to the Website of the Drug Review Center of the State Drug Administration and the Yanda database, up to now, a total of 6 domestic manufacturers (including the Company and 1 import registration) have filed a declaration, Health Yuan is the first domestic according to the new registration classification application and approved 4 classes of generic drugs manufacturers.
.